These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6179635)

  • 41. Transfer of experimental allergic encephalomyelitis with guinea pig peritoneal exudate cells.
    Driscoll BF; Kies MW; Alvord EC
    Science; 1979 Feb; 203(4380):547-8. PubMed ID: 83676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
    Lohse AW; Mor F; Karin N; Cohen IR
    Science; 1989 May; 244(4906):820-2. PubMed ID: 2471264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen.
    Willenborg DO; Bowern NA; Danta G; Doherty PC
    J Neuroimmunol; 1988 Jan; 17(2):127-35. PubMed ID: 2447124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
    Zhou SR; Whitaker JN
    J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat.
    Hickey WF; Cohen JA; Burns JB
    Cell Immunol; 1987 Oct; 109(2):272-81. PubMed ID: 2444345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis.
    Swanborg RH
    J Immunol; 1983 Apr; 130(4):1503-5. PubMed ID: 6187808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats.
    Fujinami RS; Paterson PY; Day ED; Varitek VA
    J Exp Med; 1978 Dec; 148(6):1716-21. PubMed ID: 82607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental allergic encephalomyelitis and cellular immunity in the Lewis rat.
    Vandenbark AA; Hinrichs DJ
    Cell Immunol; 1974 Apr; 12(1):85-93. PubMed ID: 4142415
    [No Abstract]   [Full Text] [Related]  

  • 50. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog.
    Stepaniak JA; Gould KE; Swanborg RH
    J Neurosci Res; 1996 Aug; 45(4):447-54. PubMed ID: 8872905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiological basis of T-cell vaccination against autoimmune disease.
    Cohen IR
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():879-84. PubMed ID: 2484252
    [No Abstract]   [Full Text] [Related]  

  • 52. Autoantibodies to glycoprotein antigens mediate subacute demyelinating encephalomyelitis in the Lewis rat.
    Gautam AM; Voccia I; Munro PM; Nolan C; Brown A; Wylie S; Glynn P
    J Neuroimmunol; 1991 Aug; 33(2):113-20. PubMed ID: 1712364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis.
    Desquenne-Clark L; Esch TR; Otvos L; Heber-Katz E
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7219-23. PubMed ID: 1714594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemorrhagic autoimmune encephalomyelitis induced by adoptive transfer of activated semiallogeneic spleen cells into irradiated rats.
    Matsumoto Y; Kawai K; Fujiwara M
    Am J Pathol; 1988 Nov; 133(2):306-15. PubMed ID: 2461090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Splenic noradrenergic and adrenocortical responses during the preclinical and clinical stages of adoptively transferred experimental autoimmune encephalomyelitis (EAE).
    Leonard JP; MacKenzie FJ; Patel HA; Cuzner ML
    J Neuroimmunol; 1990 Feb; 26(2):183-6. PubMed ID: 1688880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental allergic encephalomyelitis in the rat: enhancement and suppression by synthetic polyribonucleotides.
    Gruenewald R; Levine S; Sowinski R
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):175-9. PubMed ID: 65773
    [No Abstract]   [Full Text] [Related]  

  • 57. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat.
    Stefferl A; Linington C; Holsboer F; Reul JM
    Endocrinology; 1999 Nov; 140(11):4932-8. PubMed ID: 10537116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myelin basic protein: structure, function and antigenic determinants.
    Hashim GA
    Immunol Rev; 1978; 39():60-107. PubMed ID: 75170
    [No Abstract]   [Full Text] [Related]  

  • 60. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
    Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
    J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.